User:Mr. Ibrahem/Sonidegib

Sonidegib, sold under the brand name Odomzo, is a medication used to treat cancer, specifically basal cell skin cancer. It is used in cases in which surgery or radiation therapy has failed or is not an option. It is taken by mouth.

Common side effects include muscle spasms, hair loss, taste changes, tiredness, nausea, pain, diarrhea, vomiting, and itchiness. Other side effects may include muscle breakdown and liver problems. Use before or during pregnancy may harm the baby. It is a hedgehog signaling pathway inhibitor.

Sonidegib was approved for medical use in the United States and in the European Union in 2015. In the United States it costs about 13,000 USD per month.